The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...

Modern lifestyles, frequent prescription updates, and continuous lens enhancements drive Japan’s spectacle lens market, promoting specialized designs, robust distribution networks, and progressive ...

The company had said in December it was exploring a potential sale and other options to help its Canadian parent Bausch Health to exit the eye-care company.